C82.98
Follicular lymphoma, unspecified, lymph nodes of multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of non-Hodgkin lymphoma, which is a cancer that begins in the lymphatic system. It typically involves the growth of cancerous lymphocytes within lymph nodes, forming a follicular pattern. When the specific site of the lymphoma isn't clearly defined, it is classified as unspecified. The code C82.98 refers to cases where follicular lymphoma affects lymph nodes across multiple locations without a specified site. This condition tends to progress slowly but requires careful management due to its potential to spread to other parts of the body.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal lymphocyte growth Age-related changes, as it predominantly affects older adults Exposure to certain chemicals or radiation (though specific causes are not well established) Weakened immune system, possibly due to other medical conditions or medications
Key Symptoms: Painless swelling of lymph nodes in various parts of the body, including the neck, armpits, or groin Unexplained weight loss Fever and night sweats Persistent fatigue or tiredness Feeling of fullness or discomfort in the abdomen due to enlarged lymph nodes or spleen Frequent infections or a tendency to get sick more often
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history review, physical examinations, and various tests. These may include:
Treatment Protocols: Treatment options depend on factors such as the stage of the disease, overall health, and specific patient circumstances. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C82.98 a billable ICD-10 code?
Yes, C82.98 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.98?
Clinical documentation must specify the nature of Follicular lymphoma, unspecified, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
